A significant variation in susceptibility to paclitaxel-mediated killing was observed among a panel of short-term cultured non-small-cell lung cancer (NSCLC) cell lines. Susceptibility to killing by paclitaxel correlated with expression of the BH3-only protein, Bim, but not with other members of Bcl-2 family. NSCLC cell lines with the highest level of Bim expression are most susceptible to apoptosis induction after paclitaxel treatment. Forced expression of Bim increased paclitaxelmediated killing of cells expressing an undetectable level of Bim. Conversely, knock down of Bim, but not Bcl-2 expression, decreased the susceptibility of tumor cells to paclitaxel-mediated killing. Similar observations were made using a panel of breast and prostate cancer cell lines. Paclitaxel impairs microtubule function, causes G2/M cell cycle blockade, mitochondria damage, and p53-independent apoptosis. These results established Bim as a critical molecular link between the microtubule poison, paclitaxel, and apoptosis.
Introduction
The taxanes, paclitaxel and docetaxel, are among the most effective chemotherapeutic agents for patients with NSCLC, prostate and breast cancer. 1 Taxanes induce stabilization of microtubule formation, blockade of G2/M cell cycle transition, leading to subsequent cell death. The cell death pathways in cancer cells targeted by taxanes are not well-defined. In contrast to DNA-damaging agents, which induce p53-dependent apoptosis, antimicrotubule agents, including paclitaxel, induce apoptosis regardless of the status of p53 and loss of p53 appears to sensitize cells to cell death stimuli. [2] [3] [4] [5] [6] Two major cell death pathways have been described, one mediated by death receptors and the other mediated by mitochondria. Both pathways involve a signal cascade of caspases. For example, the initiator caspases, caspase-8, or -9, are directly activated by death receptors or cytochrome c released from mitochondria, and subsequently transmit the signal to downstream effector caspases, such as caspase-3, -6, or -7. 7 It is well established that the intrinsic apoptotic pathway mediated by mitochondria is critical for cell death induced by various forms of cell stress including the perturbation of microtubule dynamics inflicted by paclitaxel. [8] [9] [10] [11] [12] [13] This intrinsic cell death pathway is largely regulated by both pro-and antiapoptotic members of the Bcl-2 family. 14 BH3-only proapoptotic proteins are localized in different cellular compartments and situated to sense different sources of stress, whereas antiapoptotic proteins such as Bcl-2 and Bcl-xL are localized on the outer membrane of mitochondria, guiding the integrity of mitochondrial outer membrane. Previous studies demonstrated that paclitaxel induced phosphorylation of Bcl-2 2 was critical for cell death induced by paclitaxel. 15, 16 However, more recent studies showed that Bcl-2 phosphorylation occurs normally during the G2/M phase of the cell cycle 17 and raised doubt about whether Bcl-2 phosphorylation was the cause of cell death or merely a bystander event. In addition, there was poor correlation between paclitaxel resistance and expression of Bcl-2 and Bcl-xL in lung cancer cell lines; overexpression of Bcl-2 failed to protect NSCLC cell lines from paclitaxel-induced apoptosis. 18 Recently, the BH3-only proapoptotic protein Bim was shown to localize to microtubules via binding to the light chain of the dynein motor complex 19 and to be critical for paclitaxelmediated cell death of lymphocytes, 20 suggesting that Bim may be an important mediator of cell death induced by antimicrotubule agents in solid tumors.
CRI-702 and CRI-619 were the most sensitive to paclitaxelinduced killing compared to four other cell lines (Figure 1a ). To determine whether differential susceptibility of these cell lines to paclitaxel was related to differential expression of Bcl-2 family members, expression levels of Bim, Bmf, Bax, Bak, Bcl-2, and Bcl-xL were measured by Western blot analysis. Their protein levels varied greatly among these cell lines (Figure 1b) . Interestingly, the two paclitaxel-sensitive cell lines (CRI-702 and CRI-619) expressed high levels of Bim (predominantly the Bim EL isoform), while four resistant cell lines (LuCSF1, LT-30, LT-46 and LT-36) expressed a significant lower level of Bim (Figure 1b ). In agreement with published reports, expression of Bmf, Bax, Bak, Bcl-2, or Bcl-xl did not correlate with the susceptibility to paclitaxel (Figure 1b) . For example, the sensitive lines, CRI-619 and CRI-702, expressed the highest levels of Bcl-2 proteins. After 40 nM paclitaxel treatment, expression of Bim EL isoform in paclitaxel-sensitive cell line CRI-619 decreased, while expression of Bim L isoform increased. Most importantly, the most apoptotic Bim S isoform was expressed only after paclitaxel treatment (Figure 1c) . In contrast, a slight induction of Bim EL isoform was found in paclitaxel resistant cell line LuCSF1. The increased expression of Bim L isoform and the de novo synthesis of Bim S isoform were found only in detached cell population. Killing of NSCLC cell lines by paclitaxel appeared to be independent of protein neosynthesis, since actinomycin D treatment only slightly enhanced paclitaxel-mediated killing of sensitive cell lines and did not affect resistant cell lines (data not shown). To extend the connection between the level of Bim expression and paclitaxel-mediated tumor killing to other cancer types, the experiments were repeated with four breast (SK-BR-3, BrCa101, BccMcGee, and MDA) and two prostate (DU145 and PC3) cancer cell lines. Again, tumor cell lines that expressed higher level of Bim exhibited greater level of sensitivity to paclitaxel (Figure 2 ). These results suggest that, as in lymphocytes, paclitaxel-mediated killing of human carcinoma cells may also depend on Bim expression.
Paclitaxel induced apoptosis, mitochondrial damage, and caspase activation
To determine whether exposure to paclitaxel leads to caspase activation and apoptosis, CRI-702 cells were incubated with 40 nM paclitaxel for 24 h. Cells treated with paclitaxel die by apoptosis, which is manifested morphologically by membrane bubbling, nuclear condensation, and fragmentation ( Figure 3a) . Caspase activation was assessed by using fluorogenic substrates specific for caspase-2, -3, -8, and -9; paclitaxel sensitive (CRI-702) but not resistant cells (LuCSF1) exhibited a significant increase of caspase-2, -3, -8, and -9 activation (Figure 3b ). The activation of caspase-3 was confirmed by Western blot analysis of the cleavage of procaspase-3, which predominantly occurred in detached cells (Figure 3c ). Furthermore, paclitaxel treatment caused a dramatic loss of mitochondrial membrane potential in CRI-619 as measured by the fluorescent probe JC-1 (Figure 3d ). Thus, paclitaxel could induce apoptotic cell death in sensitive NSCLC cell lines.
Caspase inhibitors reduced paclitaxel-induced nuclear condensation
Paclitaxel has been shown to induce mitochondrial damage and apoptosis in both caspase-dependent and -independent manner in various cell lines. 18,21-24. To determine whether apoptosis of our NSCLC cell lines is caspasedependent, CRI-619 and CRI-702 cells were incubated with cell-permeable inhibitors to pancaspases, caspase-3, -8, and -9, and then treated with 40 nM paclitaxel for 24 h. As measured by HS-33342 nuclear staining, a low but significant blockage of nuclear fragmentation was observed in CRI-702 cells ( Figure 4a ); inhibitors to pancaspases and casapse-3 and -8 but not caspase-9 significantly decreased paclitaxel-induced apoptosis. Apoptosis of CRI-619 was greatly diminished in the presence of inhibitors to pancaspases or caspase-3 but not caspase-8 or -9 ( Figure 4b) . In all experiments, control inhibitor Z-FA-FMK did not change paclitaxel susceptibility of either cell line. These results suggest that caspases are important for paclitaxel-induced apoptosis and the requirement for which particular caspase may depend on the cell line tested. We observed approximately four-fold induction of caspase-3-like activity using DEVD substrate and a marked effect on survival after pretreatment with DEVD inhibitor; however, procaspase-3 
Forced expression of Bim increased paclitaxel susceptibility of LuCSF1 cell line
The maximum level of paclitaxel-mediated killing of LuCSF1 cells is relatively low. If it is due to the lack of Bim expression, To confirm that Bim is required for paclitaxel-mediated killing of tumor cells, the sensitivity to paclitaxel of four tumor cell lines (MDA, SK-BR-3, CRI-702, and PC3) was determined after Bim expression was transiently knocked down by Bimspecific siRNA using lipofection. Bim, but not control GFP, siRNA was able to reduce Bim expression in all four cell lines; Bak expression was not affected by either siRNA (Figure 6a has been reported previously that phosphorylation and inactivation of Bcl-2 played a critical role in paclitaxelmediated killing. 15, 16 As phosphorylation and inactivation of Bcl-2 occurs during the G2/M phase of normal cell cycle, 17 it remains controversial whether Bcl-2 is required for paclitaxel-mediated killing. To determine whether paclitaxel-mediated killing of tumor cells requires expression of Bcl-2, knockdown experiments were repeated with Bcl-2 siRNA by lipofection. Bcl-2, but not control GFP, siRNA was able to reduce Bcl-2 expression in all three cell lines; Bak expression was not affected by either siRNA (Figure 7a) . In contrast to Bim siRNA, no significant difference of killing was observed following transfection with either Bcl-2 or GFP siRNA (Figure 7b ). Once again, transfection with siRNA alone did not significantly change the basal level of cell death in all cell lines (Figure 7c ).
Stable knockdown Bim expression decreased sensitivity to paclitaxel-mediated killing in CRI-619 cell line
In previous experiments, we used the transient lipofection method to deliver siRNA into tumor cells. We observed that the control GFP siRNA sometimes could reduce the killing mediated by paclitaxel, albeit at a lower level compared to Bim siRNA. This could be due to the activation of PKR or other signaling pathways that often associated with transient transfection. To overcome this problem, we generated stable knockdown cell lines using retroviral vector system. After selection with puromycin, we established two cell lines derived from CRI-619, CRI-619 Bim siRNA and CRI-619 luc siRNA. CRI-619 tumor cells expressing Bim siRNA, but not control luciferase siRNA, decreased Bim EL and Bim L expression, while Bak expression was not affected by either siRNA (Figure 8a ). Consistent with results obtained from transient knockdown experiments, a significant decrease in killing levels was observed in CIR-619 Bim siRNA compared to the control CIR-619 luc siRNA or parental CRI-619 cells (Figure 8b ). The levels of killing were also determined with HS-33342 staining assay and similar results were obtained (data not shown).
Discussion Paclitaxel, cell cycle arrest, and apoptosis
It is well established that antimicrotubule drugs such as paclitaxel induce G2/M arrest by activating spindle checkpoints. 26, 27 Cell death induction by antimicrotubule drugs requires the spindle check point signals. Treated with a low concentration of paclitaxel, checkpoint-deficient cells become polyploid and survive, while checkpoint-proficient cells exit mitosis and enter G1 followed by apoptosis. 24, 28 Recent studies strongly support this notion, since amplification of Aurora-A leads to paclitaxel resistance by over-riding the mitotic spindle checkpoint. 29 It was also found that mitotic spindle checkpoint-deficient lung cancer cells were highly resistant to antimicrotubule agents and checkpoint-proficient lung cancer cells became highly resistant when mitotic arrest was abrogated by treatment with staurosporine. 30 The link between the activation of spindle checkpoint and subsequent cell death is unknown. Taxanes and new classes of microtubule-stabilizing drugs, discodermolide and epothilone B, have been shown to induce caspase and mitochondrial-independent apoptosis in NSCLC, ovarian, and breast cancer cells. 18, 31 Bim has a critical role in lymphocyte apoptosis induced by both cytokine withdrawals 20 and TCR stimulation, 32 and is required for neuronal cell death after NGF deprivation. 33 Paclitaxel-induced apoptosis of lymphoma cells appeared to be caspase-dependent and involved mitochondria amplification loop. 34 Our results showed that Bim-dependent apoptosis induction in sensitive cell lines was at least partially caspase-dependent. The most likely explanation for the discrepancy between our results and other reports may be explained by differences in the cell lines used. Our study investigated apoptosis in two cell lines that were relatively sensitive to paclitaxel, while paclitaxel induced a less efficient apoptosis in the H460 cells used in their study. Resistance to chemotherapy was often associated with dysfunction of mitochondrial death machinery and caspase inhibition. [35] [36] [37] [38] In these cell lines, cell death may rely on other less-defined pathways when the major cell death mechanisms are either missing or blocked. It has been reported that apoptosis induction in caspase-inefficient NSCLC cells may involve an AIF-mediated and caspase-independent mechanism. 38 Caspase-independent necrosis-like cell death can occur via serine proteases 39 or via the hypoxia-inducible BH3-only proapoptotic protein Bnip3. 40, 41 Unlike other BH3-only proteins, Bnip3-induced apoptosis required neither Apaf-1/ cytochrome c nor caspases. 40, 41 However, the participation of such pathways in paclitaxel induced-cell death has not been explored. Nevertheless, the ability of IAP antagonist Smac/Diablo to sensitize cells to paclitaxel-induced apoptosis strongly supports the notion that caspase activation is important for the robust cell death in sensitive cell lines and resistant cell lines after neutralization of caspase inhibitors. 22, 34, [42] [43] [44] In addition, it is worth noting that activation of p34 cdc2 cyclin kinase by paclitaxel leads to increased expression of survivin, a protein that regulates mitosis and inhibits apoptosis; blocking survivin expression by inhibiting p34 cdc2 kinase resulted in massive mitochondrial-mediated apoptosis. 45 
Regulation of Bim
Bim is expressed by cells of hematopoietic, neuronal, and epithelial lineage. 46 Three major isoforms of Bim (Bim EL , Bim L , and Bim S ) exist due to alternative splicing. 47 Regulation of Bim has been reported at both transcriptional and posttranscriptional levels. In neuronal and other type cells, Bim expression was shown to be controlled by the FOXO3 transcriptional factor, which involved Akt/PKB. 48, 49 Currently, it is not known what regulates Bim expression and function in prostate and NSCLC cell lines. It will be interesting to examine whether expression of Bim in prostate and NSCLC cell lines is also regulated by FOXO3 or other related members as recently shown for breast cancer cell lines. 50 Our current study only examined the constitutive expression of Bim by different cell lines; the potential upregulation of Bim by paclitaxel treatment may also play a critical role in apoptosis induction. In fact, we found that paclitaxel could induce a high level of de novo expression of Bim S isoform in sensitive CRI-619 and upregulation in CRI-702 cells. Bim S isoform is the most potent inducer of apoptosis due to the lack of the dynein light-chain binding domain (present in both Bim EL and Bim L isoforms) and phosphorylation sites for Erk MAPKs (present only in Bim EL isoform). Regulation of alternative splicing of Bim by paclitaxel has not been studied and will be one interesting area for future investigation.
The proapoptotic activity of Bim was also found to be regulated by the MAPKs at post-transcriptional levels. Two different but inter-related mechanisms have been proposed for the post-transcriptional regulation of Bim: sequestration to microtubules via binding to the light chain of the motor complex 19 and JNK-dependent phosphorylation. 51, 52 Lei et al. showed that Bim L and Bmf were normally sequestered by binding to dynein and myosin V motor complexes and phosphorylation by JNK caused their release and mediated apoptosis induction by UV light. 52 The phosphorylation site (Thr 56 ) of Bim L is within the binding site of dynein light chain, LC8. It is clear that Bim phosphorylation by JNK played an important role in neuronal cell death, although phosphorylation of Bim EL was found to be at a different one, Ser 65 , which is outside the LC8 binding site. 51 However, it is not clear whether release from the sequestration of Bim by the dynein complex played any significant role in neuronal cell death since induced Bim EL was localized exclusively to mitochondria. Mostly importantly, it is still not known how phosphorylation of Bim might promote the proapoptotic activity of Bim L or Bim EL .
Bim is regulated also at the post-translational level. While JNK appeared to regulate Bim activation, Erk members of MAPK family have been shown to modulate Bim protein levels via proteasome degradation pathways. It has been recently demonstrated that phosphorylation of Bim EL by Erk1/2 on Ser 65 selectively leads to its proteasome degradation. [53] [54] [55] Recent studies have demonstrated that EGFR prevented anoikis by blocking induction of Bim expression in breast cancer cell lines via Erk-dependent pathways. 56 As paclitaxel induces activation of MAPKs, [57] [58] [59] [60] it will be important to determine whether the differential expression of Bim observed is caused by different levels of constitutive Erk1/2 phosphorylation associated with the cancer cells examined. 61 
Summary
Antimicrotubule drugs represent an important class of chemotherapeutics for various solid tumors. The underlying mechanisms by which these drugs induce mitochondriamediated apoptosis are largely unknown. This report represents an important initial step in elucidation of such mechanisms. Future studies are needed to identify the potential molecular links between the activation of the mitotic spindle checkpoint and activation of Bim by JNK. In addition, elucidation of the mechanisms that regulate expression and proapoptotic activity of Bim in cancer cells will yield important information for the development of novel chemotherapeutic drugs and combination strategies.
Materials and Methods
Cell culture and paclitaxel killing 
Western blot analysis
Cell lysates were prepared and quantified by the BCA method as described previously. 62 Protein (10 mg/lane) was resolved by SDS-PAGE and transferred to PVDF (polyvinylidene difluoride) membranes according to the manufacturer's instructions (Invitrogen Life Technology Inc., Carlsbad, CA, USA). The membranes were blotted with antibodies specific for Bim (Oncogene, Boston, MA, USA), Bcl-xL (eBioscience, San Diego, CA, USA), Bak, Bcl-2, Bax (Upstate Biotechnology, Lake Placid, NY, USA), and b-actin (Sigma, MO, USA), and detected with anti-mouse IgG-HRP (Molecular Probes, Eugene, OR, USA) and ECL reagents as recommended by the manufacturer (Amersham Biosciences, Piscataway, NJ, USA). In some experiments, Bim was immunoprecipitated first before Western blot analysis to increase the sensitivity of detection.
Retroviral transduction
Tumor cells were transduced with the murine stem cell virus pMIG-BimL virus or with the pMIG control virus as described previously. 62 Briefly, Bim and Bcl-2 knock down by siRNA Bim, Bcl-2, and GFP siRNA were prepared as described (esiRNA). 63 The forward primer of Bim L with T7 sequence is TAA TAC GAC TCA CTA TAGG GAG ACA GGA TGG CAA AGC AAC CTT CTG. The reverse primer of Bim L with T7 sequence is TAA TAC GAC TCA CTA TAGG GAG ACA GGT CAA TGC ATT CTC CAC AC. The forward primer of Bcl-2 with T7 sequence is TAA TAC GAC TCA CTA TAGG ATG GCG CAC GCT GGG AGA AC. The reverse primer of Bcl-2 with T7 sequence is TAA TAC GAC TCA CTA TAGG TCA CTT GTG GCC CAG ATA. Briefly, the fulllength double-strand RNA was prepared by the in vitro transcription from Bim L , Bcl-2, and GFP cDNA, and digested with RNase III to yield 15-23 bp small RNA. Cells (2 Â 10 5 cells/well in six-well plate) were transfected twice with Bim, or Bcl-2 or GFP siRNA (0.25 mg/ml siRNA for CRI-702, 0.5 mg/ml siRNA for SKBr3, MDA, and PC3), using Lipofectamine 2000 reagent (Invitrogen Life Technology Inc., CA, USA) following the manufacturer's protocol. At 24 h post-transfection, Bim, Bcl-2, and Bak expression of transfected cells was determined by Western blot analysis and susceptibility to killing by paclitaxel was determined as above.
Establish stable CRI-619 cell line expressing stable Bim siRNA 
Caspase activation and inhibition assays
The caspase substrates, Ac-VDVAD-AFC, Ac-DEVD-AFC, Ac-IETD-AFC, and Ac-LEHD-AFC, were used to measure caspase-2, -3, -8, and -9 activities, respectively, as recommended by the manufacturer (Pharmingen, CA, USA). Briefly, after incubation with paclitaxel, both the floating cells and adherent cells were collected and lysed in 150 ml of RIPA lysis buffer. For each reaction, 50 ml lysate and 5 ml reconstituted substrate were incubated for 1 h at 371C in a 96-well plate. AFC fluorescence intensity was measured using a Wallac 1420 Victor 2 with an excitation wavelength and emission set at 355 and 460 nM, respectively. Reconstituted substrate plus HEPES buffer alone was used to determine the background level of AFC fluorescence intensity. Induction fold was calculated as AFC fluorescence with paclitaxel treatment minus background fluorescence divided by AFC fluorescence without paclitaxel treatment minus background. For inhibition of caspases, cells were first incubated with 50 mM control inhibitor (Z-FA-FMK), and pan-caspase (Z-VAD-FMK), caspase-3 (Z-DEVD-FMK), -8 (Z-IETD-FMK), and -9 (Z-LEHD-FMK) inhibitors (EMD Bioscience Inc., San Diego, CA, USA) for 40 min before paclitaxel treatment. After 24 h, Hoechst nuclear staining was used to enumerate apoptotic nuclei: small, bright, and condensed nuclei indicate apoptotic cells. Cells were first fixed with ethanol and the DNA-specific dye Hoechst 33342 (Molecular Probes, OR, USA) was added to cells at a final concentration of 0.5 mg/ml. The percentage of apoptotic nuclei was determined by first taking images from four different fields under a fluorescence microscope with 480 nM filter. Each image contained 50-100 cells, and the percentage of apoptotic cells was calculated by dividing the number of cells with bright and small nuclei by the total number of cells.
Measurement of mitochondrial membrane potential with the fluorescent probe JC-1 CRI-619 cells were incubated with or without 40 nM paclitaxel for 24 h and stained with 10 mg/ml JC-1 (Molecular Probes) at room temperature for 10 min. After washing with PBS, cells were analyzed by flow cytometry. Cells with polarized mitochondria presented in the upper-right quadrant of the dot plot due to the formation of JC-1 aggregates (J aggregates), which emit orange color (590 nM) when excited at 488 nM. Cells with depolarized mitochondria emit green color (530 nM) and are visualized in the lowerright quadrant in the dot plot. 
